This invention relates to stable pharmaceutical compositions for parenteraladministration comprising dopamineagonists and peripheral acting agents.useful for treatment of metabolicdisorders or key elements thereof. The parenteral dosageforms exhibit long stable shelf life and distinct pharmacokinetics.